510(k) Report

510(k) · Cleared

Recalled · 2010

Access Sex Hormone Binding Globulin Reagent, Access Sex Hormone Binding Globulin Calibrators and Access Sex Hormone Bind

K083867510(k) TraditionalCleared Aug 27, 2009241-day reviewClass I21 CFR 862.1680Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Beckman Coulter, Inc. · CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

Cleared on Aug 27, 2009 as substantially equivalent to K941797 (Diagnostic Products Corp., 1994) after a 241-day review. Its family tree reaches back 1 generation to 1994. 2 later devices descend from it. It has been recalled once.

Decided
Aug 27, 2009
Review
241 days
Class
Class I
Product code
CDZ
Recalls
1
Predicates
1

Its longest line of descent runs back 1 generation to K941797 (1994). 2 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2024: 1 descendant cleared2019: 1 descendant clearedK941797 · Immulite SHBG · Diagnostic Products Corp. · 19941990200020102020
Descendants, by generation 1 generation forward: 2 descendants K941797 · Immulite SHBG · Diagnostic Products Corp. · 19940
  1. Root · 1 generation backK941797 Immulite SHBGDiagnostic Products Corp. · 1994
  2. This deviceK083867 Access Sex Hormone Binding Globulin Reagent, Access Sex Hormone…Beckman Coulter, Inc. · 2009
  3. Descendant · cites it directly · 0 of its ownK233480 Access SHBGBeckman Coulter, Inc. · 2024
  4. Descendant · cites it directly · 0 of its ownK182521 FastPack IP Sex Hormone Binding Globulin ImmunoassayQualigen, Inc. · 2019 · Recalled

Most influential descendants

Showing 2 of 2 · See all
  • K233480Access SHBGBeckman Coulter, Inc. · 2024 · cites it directly0descendants
  • K182521FastPack IP Sex Hormone Binding Globulin ImmunoassayQualigen, Inc. · 2019 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K941797Immulite SHBGDiagnostic Products Corp.1994—
0 (this device)K083867Access Sex Hormone Binding Globulin Reagent, Access Sex Hormone Binding…Beckman Coulter, Inc.2009—
+1K233480Access SHBGBeckman Coulter, Inc.2024—
+1K182521FastPack IP Sex Hormone Binding Globulin ImmunoassayQualigen, Inc.20192

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201910
202410
FIG. 1 — Lineage of K083867, 1994–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CDZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CDZ device

  1. #1 K252728 IDS-iSYS Total Testosteronescore 11.8 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K941797Immulite SHBG
Summary page 2
…the sample is determined from a stored, multi-point calibration curve. Predicate Device: DPC Immulite SHBG ~ (K941797) The IMMULITE SHBG assay and IMMULITE 2000 analyzer are registered trademarks of Siemens Healthcare Diagnostics. Beckman…
Diagnostic Products Corp.1994—

Also cleared against K941797: 1 other device →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K233480Access SHBGBeckman Coulter, Inc.20240
K182521FastPack IP Sex Hormone Binding Globulin ImmunoassayQualigen, Inc.20190

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 26, 2010Not classifiedZ-0431-2011PendingThe recall was initiated because the Instruction for Use (IFU) for Access SHBG does not specify the units of measure to be used when calculating the Free Androgen Index (FAI %). Access SHBG (nmol/L) values and Access Testosterone (ng/mL)…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K233480 (Beckman Coulter, Inc., 2024) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K941797.

How does its category compare?

All CDZ devices

CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · CDZ

2in 2024

2007: 12009: 12010: 22011: 22012: 12013: 12014: 12015: 22016: 42018: 12019: 42020: 12022: 12023: 12024: 22026 (partial year): 1
2007high 4 (2016) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CDZ

141in 2019

2016: 276 days median2019: 141 days median
2007high 276 (2016) · low 141 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CDZ

1in 2025

2010: 12013: 12018: 12022: 12024: 12025: 12026 (partial year): 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CDZ

17in 2025

2007: 62008: 32009: 12010: 12011: 192012: 92013: 72014: 102015: 72016: 52017: 122018: 52019: 32020: 122021: 72022: 32023: 102024: 112025: 17
2007high 19 (2011) · low 1 (2009)2025

MAUDE reports naming product code CDZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—06
20080—03
20091—01
20102—11
20112—019
20121—09
20131—17
20141—010
20152—07
2016427605
20170—012
20181—15
2019414103
20201—012
20210—07
20221—13
20231—010
20242—111
20250—117
20261—1—

What is it indicated for?

The Access SHBG assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of Sex Hormone Binding Globulin levels in human serum and plasma using the Access Immunoassay Systems. The Access Sex Hormone Binding Globulin assay is indicated for use in the assessment of androgen disorders.

The Access SHBG Calibrators are intended to calibrate the Access SHBG assay for the quantitative determination of Sex Hormone Binding Globulin levels in human serum and plasma using the Access Immunoassay Systems.

The Access SHBG QC is intended for monitoring system performance of the Access SHBG assay.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K083867: Access Sex Hormone Binding Globulin Reagent, Access Sex Hormone Binding Globulin Calibrators and Access Sex Hormone Bind.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K083867

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026